HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Existing Safety Principles Suffice For Nano-Cosmetics Evaluation – FDA

This article was originally published in The Rose Sheet

Executive Summary

FDA maintains that the current framework for cosmetic safety assessment is sufficient to control potential risks associated with nano-engineered cosmetics. However, traditional testing methods may need to be modified or new strategies developed to account for nanomaterials’ unique properties and behavior, the agency says in final guidance issued June 24.

You may also be interested in...



EC's Delayed Nano Inventory Reflects Notification Errors, Definitional Challenges

A European Commission official says the long-awaited cosmetic nanomaterials inventory has been delayed due to notification inaccuracies, likely reflecting challenges associated with the "nanomaterial" definition enshrined in regulations. Nevertheless, the EC says it is nearing completion, and trade group Cosmetics Europe believes the catalogue could release this summer.

FDA May Work Cosmetics Into Food Additive Safety-Assessment Guidance

FDA proposes wrapping cosmetics and dietary supplements into its guidance laying out toxicological principles for assessing food and color additive safety.

FDA Could Stir Supplements Into Food Additive Safety-Assessment Guidance

FDA proposes wrapping dietary supplements and cosmetics into its guidance laying out toxicological principles for assessing food and color additive safety.

Related Content

UsernamePublicRestriction

Register

RS019097

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel